Literature DB >> 16162767

Hypercholesterolemia attenuates the anti-ischemic effect of preconditioning during coronary angioplasty.

Imre Ungi1, Tamás Ungi, Zoltán Ruzsa, Edit Nagy, Zsolt Zimmermann, Tamás Csont, Péter Ferdinandy.   

Abstract

BACKGROUND: Cardioprotection by preconditioning is limited in some animal models of hypercholesterolemia. We studied ischemic preconditioning induced by coronary angioplasty in hypercholesterolemic and normocholesterolemic patients by means of a beat-to-beat analysis of ST segments.
METHODS: Thirty coronary disease patients were classified into normocholesterolemic and hypercholesterolemic groups. Intracoronary ECG was recorded during three consecutive balloon inflations of 2-min duration with 5-min intervals.
RESULTS: In normocholesterolemic patients, the ST segment was continuously elevated during the occlusions and rapidly normalized after balloon deflations. Repeated occlusions significantly attenuated ST-segment elevation from 1.28 +/- 0.67 to 0.88 +/- 0.51 mV (p < 0.001) and decreased the time to normalization of ST segment. In hypercholesterolemic patients, the ST segment was rapidly elevated in the first 30 s of the first occlusion, and normalization of the ST segment was longer on the first reperfusion. However, in these patients, repeated occlusions abolished the initial elevation of the ST segment but did not attenuate maximal ST-segment elevation (1.24 +/- 1.11 mV vs 1.21 +/- 1.09 mV) and failed to decrease the time to normalization of the ST segment.
CONCLUSIONS: Hypercholesterolemia accelerates the evolution of myocardial ischemia, delays recovery on reperfusion, and deteriorates the anti-ischemic effect of preconditioning in humans.

Entities:  

Mesh:

Year:  2005        PMID: 16162767     DOI: 10.1378/chest.128.3.1623

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  22 in total

Review 1.  Effect of hypercholesterolaemia on myocardial function, ischaemia-reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.

Authors:  Ioanna Andreadou; Efstathios K Iliodromitis; Antigone Lazou; Anikó Görbe; Zoltán Giricz; Rainer Schulz; Péter Ferdinandy
Journal:  Br J Pharmacol       Date:  2017-02-08       Impact factor: 8.739

Review 2.  Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Authors:  Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2018-08-17       Impact factor: 17.165

3.  Effect of zinc supplements in the attenuated cardioprotective effect of ischemic preconditioning in hyperlipidemic rat heart.

Authors:  Sunil Kumar Kansal; Uma Jyoti; Samridhi Sharma; Arun Kaura; Rahul Deshmukh; Sandeep Goyal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-03-07       Impact factor: 3.000

Review 4.  The role of comorbidities in cardioprotection.

Authors:  Michael N Sack; Elizabeth Murphy
Journal:  J Cardiovasc Pharmacol Ther       Date:  2011 Sep-Dec       Impact factor: 2.457

5.  Luteolin alleviates cardiac ischemia/reperfusion injury in the hypercholesterolemic rat via activating Akt/Nrf2 signaling.

Authors:  Jin-Ting Yang; Jue Wang; Xin-Ru Zhou; Chi Xiao; Yang-Yun Lou; Li-Hui Tang; Feng-Jiang Zhang; Ling-Bo Qian
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-04-18       Impact factor: 3.000

Review 6.  Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.

Authors:  Karin Przyklenk
Journal:  Drugs Aging       Date:  2011-05-01       Impact factor: 3.923

7.  Involvement of GSK-3β in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart.

Authors:  Harlokesh Narayan Yadav; Manjeet Singh; P L Sharma
Journal:  Mol Cell Biochem       Date:  2010-05-30       Impact factor: 3.396

8.  Remote Limb Ischemic Conditioning and Motor Learning: Evaluation of Factors Influencing Response in Older Adults.

Authors:  Ellen N Sutter; Anna E Mattlage; Marghuretta D Bland; Kendra M Cherry-Allen; Elinor Harrison; Swati M Surkar; Jeffrey M Gidday; Ling Chen; Tamara Hershey; Jin-Moo Lee; Catherine E Lang
Journal:  Transl Stroke Res       Date:  2018-08-07       Impact factor: 6.829

Review 9.  Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.

Authors:  Takayuki Miki; Takahito Itoh; Daisuke Sunaga; Tetsuji Miura
Journal:  Cardiovasc Diabetol       Date:  2012-06-13       Impact factor: 9.951

10.  Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats.

Authors:  Márta Sárközy; Agnes Zvara; Nóra Gyémánt; Veronika Fekete; Gabriella F Kocsis; Judit Pipis; Gergő Szűcs; Csaba Csonka; László G Puskás; Péter Ferdinandy; Tamás Csont
Journal:  Cardiovasc Diabetol       Date:  2013-01-15       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.